Trial Profile

A Study of ARRY 371797 in Patients With Osteoarthritis of the Knee.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 16 Oct 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Emprumapimod (Primary) ; Oxycodone
Indications Musculoskeletal pain
Focus Biomarker; Therapeutic Use
Sponsors Array BioPharma; Pfizer

Most Recent Events

14 Nov 2012 Results presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
06 Nov 2012 Final results were presented in a late-breaking abstract at the Annual Meeting of the American College of Rheumatology (ACR) in November 2012.
31 Jul 2012 Primary endpoint 'Western-Ontario-and-McMaster-Universities-Osteoarthritis-Index' has been met.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com